市场调查报告书
商品编码
1492261
血管镜设备市场:可用性,按最终用户划分 - 2024-2030 年全球预测Angioscope Device Market by Usability (Disposable Angioscopes, Reusable Angioscopes), End User (Diagnostic Centers, Hospitals, Research & Academic Institutes) - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
血管镜设备市场规模预估2023年为2.5158亿美元,2024年达2.6677亿美元,预计2030年将达到3.912亿美元,复合年增长率为6.50%。
血管镜设备市场包括专为血管镜检查而设计的医疗设备,血管镜检查是一种允许医疗专业人员透过配备光源和摄影机的小型柔性管可视化血管和器官内部的手术,称为医疗设备。周边动脉疾病和冠状动脉疾病等疾病的增加刺激了对诊断和治疗程序(包括血管镜检查)的需求。血管镜设备的创新,包括增强的成像功能和用户友好的介面,正在提高其功能和有效性,并吸引更多的医疗保健提供者。由于微创手术相对于传统开放性手术的优势,患者和医生对微创手术的日益偏好也推动了市场的扩张。然而,医疗设备核准的严格监管要求可能会减缓新创新的市场进入并限制市场范围。确保复杂血管镜系统的品质和可靠性需要大量的专业知识和培训,这给医疗保健专业人员带来了挑战。此外,将血管镜设备与人工智慧等数位工具相结合可以实现更好的影像分析和病患监测,从而为市场成长开闢新的途径。对紧凑型穿戴式血管镜技术的持续研究可能会彻底改变门诊病人护理和远端监控,从而在未来几年创造市场扩张机会。
主要市场统计 | |
---|---|
基准年[2023] | 25158万美元 |
预测年份 [2024] | 2.6677 亿美元 |
预测年份 [2030] | 3.912 亿美元 |
复合年增长率(%) | 6.50% |
区域洞察
在美洲,特别是在美国和加拿大,由于人口老化和心血管疾病的严重流行,对先进医疗技术的需求很高。高额医疗支出和有利的报销政策进一步推动了这些技术在美洲地区的采用。在欧盟国家,人们强烈渴望得到发达的公共医疗体系和健康保险支持的高品质治疗。欧洲严格的法规环境确保市场上只有最可靠、最有效的医疗设备,其中德国、法国和英国在医疗设备使用方面处于领先地位。中东和非洲地区的情况好坏参半,沙乌地阿拉伯和阿联酋等波湾合作理事会(GCC)国家增加了对医疗技术(包括血管镜设备)的投资。亚太地区是血管镜市场成长最快的地区,医疗基础设施的增加、医疗旅游业的增加以及健康意识的提高等因素促进了该地区的市场成长。日本因其先进的医疗保健技术和对医学研究的大量投资而成为重要市场。中国和印度是新兴市场,由于医疗保健政策的改善和不断增长的中阶寻求更好的医疗保健,采用率正在增加。
FPNV定位矩阵
FPNV 定位矩阵对于评估血管镜设备市场供应商的市场定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可对血管镜设备市场供应商的当前状态进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析还提供了对该行业竞争力的宝贵见解,包括研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在血管镜设备市场中的地位进行全面评估,使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[183 Pages Report] The Angioscope Device Market size was estimated at USD 251.58 million in 2023 and expected to reach USD 266.77 million in 2024, at a CAGR 6.50% to reach USD 391.20 million by 2030.
The angioscope device market includes an arena of medical devices designed for angioscopy, a procedure that allows healthcare professionals to visualize the interior of blood vessels and organs through a small, flexible tube equipped with a light source and camera known as an angioscope. An increase in conditions such as peripheral artery disease and coronary artery disease fuels the demand for diagnostic and therapeutic procedures involving angioscopy. Innovations in angioscope devices, including enhanced imaging capabilities and user-friendly interfaces, have improved their functionality and effectiveness, attracting more healthcare providers. Rising preference for minimally invasive surgeries among patients and doctors alike for their benefits over traditional open surgeries supports market expansion. However, stringent regulatory requirements for approval of medical devices can delay market entry for new innovations, limiting the market scope. Ensuring the quality and reliability of intricate angioscope systems demands significant expertise and training, posing challenges for healthcare providers. Moreover, coupling angioscope devices with digital tools such as AI for better imaging analysis and patient monitoring may offer new avenues for growth in the market. Ongoing research into compact, wearable angioscope technology could revolutionize outpatient care and remote monitoring, generating opportunities for market expansion in upcoming years.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 251.58 million |
Estimated Year [2024] | USD 266.77 million |
Forecast Year [2030] | USD 391.20 million |
CAGR (%) | 6.50% |
Regional Insights
In the Americas, particularly in the United States and Canada, there is a high demand for advanced medical technologies due to an aging population and a significant prevalence of cardiovascular diseases. High healthcare expenditure and favorable reimbursement policies further support adopting these technologies in the Americas region. European Union countries strongly prefer high-standard medical treatments supported by extensive public healthcare systems and health insurance coverage. Europe's stringent regulatory environment ensures that only the most reliable and effective devices are available in the market, with Germany, France, and the UK leading in medical device usage. The Middle East and Africa region presents a mixed scenario where the Gulf Cooperation Council (GCC) countries such as Saudi Arabia and the UAE show increasing investment in health technology, including angioscope devices. Asia Pacific is a rapidly growing region in the market for angioscope devices, and factors such as increasing healthcare infrastructure, rising medical tourism, and growing health awareness are contributing to the market growth in the region. Japan stands out as a significant market with advanced healthcare technologies and substantial investment in medical research. China and India are emerging markets with increasing adoption rates due to improving healthcare policies and the rise of middle-class populations demanding better medical care.
Market Insights
The market dynamics represent an ever-changing landscape of the Angioscope Device Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Angioscope Device Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Angioscope Device Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Abbott's Introduction of AI-Enhanced Vascular Imaging in India, Revolutionizing Cardiac Care
Abbott Laboratories has introduced a cutting-edge vascular imaging platform in India, which is enhanced by Ultreon 1.0 Software. The advanced system integrates optical coherence tomography (OCT) with artificial intelligence (AI) to provide doctors with a detailed view of blood flow and vessel blockages, enabling precise measurements of vessel diameters. The newly launched technology substantially improves the accuracy of stent deployment during coronary procedures by offering real-time, high-definition imagery from within the blood vessels. [Published On: 2023-10-17]
Canon Medical Launches Alphenix Evolve Edition Angiography System in European Market
Canon Medical Systems Corporation has launched the Alphenix / Evolve Edition angiography system, designed to support percutaneous coronary intervention (PCI) and structural heart disease procedures by utilizing deep learning technology for enhanced imaging and reduced operational times and radiation doses. The system is a part of Canon Medical's aEvolve portfolio, which integrates AI-driven technologies to aid real-time diagnostic and therapeutic decision-making processes seamlessly within existing workflows. [Published On: 2023-08-07]
Abbott Acquires Cardiovascular Systems, Inc. to Enhance Vascular Treatment Technologies
Abbott Laboratories has entered into a definitive agreement to acquire Cardiovascular Systems, Inc. (CSI), a pioneer in the development of atherectomy systems for the treatment of arterial diseases, for approximately USD 890 million. The acquisition is set to enrich Abbott's portfolio with cutting-edge vascular technologies and an experienced team, reinforcing its position in the vascular intervention market. [Published On: 2023-02-08]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Angioscope Device Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Angioscope Device Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Boston Scientific Corporation, Canon Medical Systems, Cardinal Health, Cook Medical, Fujifilm Holdings Corporation, GE Healthcare, Hitachi Medical Corporation, Johnson & Johnson Services, Inc., Karl Storz, LivaNova PLC, Medtronic PLC, Olympus Corporation, Philips Healthcare, Shimadzu Corporation, Siemens Healthineers, Smith & Nephew PLC, Stryker Corporation, Terumo Corporation, Vena Medica, and Zimmer Biomet.
Market Segmentation & Coverage